Reintroducing Pazopanib Reverses the Primary Resistance of Nivolumab in a Patient With Metastatic Clear-cell Renal Cell Carcinoma.
作者信息
Yu-Li Su Harvey
机构信息
Division of Hematology Oncology, Department of Internal Medicine, Kaohsiung Chang Gung Memorial Hospital and Chang Gung University, College of Medicine, Kaohsiung City, Taiwan; Clinical Trial Center, Kaohsiung Chang Gung Memorial Hospital, Kaohsiung City, Taiwan.
出版信息
Clin Genitourin Cancer. 2018 Apr;16(2):114-116. doi: 10.1016/j.clgc.2017.12.002. Epub 2017 Dec 21.
PMID:29329663
Abstract
摘要
Zotero 插件